Live feed16:31:02·1327dSECFilingvia QuantisnowBrooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial ObligationByQuantisnow·Wall Street's wire, on your screen.BTX· BlackRock Technology and Private Equity Term TrustOriginal source